2nd KEMRI Annual Scientific & Health Conference (KASH)

In order to view this object you need Flash Player 9+ support!

Get Adobe Flash player

Powered by RS Web Solutions

Thursday, August 21, 2014
Text Size
   

Course Announcement

course announcement 2014

In the News

ebola-advisoryVital information on Ebola Virus Disease The Government of Kenya in collaboration with other key health stakeholders has made preparations to stop the...
kemri-kicked-off-a-week-long-hepatitis-testing-and-vaccination-in-nairobi-and-uasin-gishu-counties-to-commemorate-the-2014-world-hepatitis-day A member of the public receiving a free hepatitis vaccine Bomb Blast commemoration park at the Central Business District in Nairobi during the one week...
devolution-meeting-at-kemri Kenya Medical Research Institute (KEMRI) Board of Management Chairperson Prof. Ruth Nduati, addressing the Research Health prioritization Workshop...
county-executives-for-health-officials-to-work-with-kemri The County Executives for Health (CEH) officials and the Kenya Medical Research Institute have resolved to strengthen partnerships for better healthcare...
traditional-medicine-practitioners-told-to-work-with-kemri-in-drugs-development- Traditional Medicines Practitioners under the One Village One Product Programme (OVOP) pose for a picture with Center for Traditional Medicines and...

Calendar of Events

August 2014 September 2014
Su Mo Tu We Th Fr Sa
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Newsletters

                       

FACESNewsletter_21st_Page_1

KEMRI Bioethics Review Issue 2 2014_Page_01

TMDDP_2_newsletter

KENYA MEDICAL RESEARCH INSTITUTE (KEMRI)
2nd KEMRI Annual Scientific & Health Conference (KASH)

Theme: Towards A Healthy, Globally Competitive Nation: Vision 2030 Flagships

Dr. Edwin Muinga

Dr. Edwin Muinga Chokwe, HSC,
Chairman, KEMRI Board of Management

Attaining Kenya Vision 2030, the nation's economic blueprint, requires a fresh perspective in the way we perceive research and KEMRI's role in national development. The link between health and poverty is self evident as each impacts the other resulting in a vicious cycle where poor health is both a result and a cause of poverty.

As such the dealing with one without being cognizant of the other only serves to derail the desired impact. Health research should therefore be linked to economic development through the promoting of human and social development, and also more directly through industrialization as we strive to attain a knowledge-economy driven, middle income status by the year 2030. This was reflected in the theme of this year's conference, "Towards a healthy, globally competitive nation: Vision 2030 flagships," which affirms KEMRI's role not just in human and social development but also in the knowledge economy through the innovation of R&D outputs.

 

Bridging the Gap in Health Research in Africa

This conference therefore serves to showcase excellence in research as the bedrock of this theme. Two major ground breaking research results emanating from research carried out by KEMRI and our collaborators have recently been listed among the top 10 technological breakthroughs of the year by the journal Science. This includes the phase III clinical trial results of the candidate malaria vaccine RTSS, which reported 56 percent and 47 percent efficacy in the prevention of clinical and severe malaria in children respectively. The multicentre trial was conducted in 11 sites across 7 African countries, in which KEMRI played a significant role, having hosted 3 of the 11 sites at the KEMRI/CDC Research and Public Health Collaboration in Kisumu, the KEMRI-Wellcome-Trust Research Programme in Kilifi and the KEMRI/Walter Reed Project site at Kombewa.

The other major breakthrough in which KEMRI has been involved is the HIV Prevention Trials Network (HPTN) multinational clinical study, HPTN 052, which demonstrated reduction of HIV transmission in serodiscordant couples through the early treatment of HIV using ARVs by an astounding 96 percent. Both studies have served to inform policy and revitalize the fight against the scourge of these diseases not just in Kenya but the world over.

Additionally, KEMRI remains committed to the national and WHO roadmaps for the control and elimination of 10 of the 17 neglected tropical diseases by the year 2020. Significant advances have been made on this front with results emanating from DNDi, of which KEMRI is both a founding member and partner through CCR, have informed the WHO recommendation of paramomycin-sodium

 stibogluconate (PM-SSG) drug combination as the first line treatment for visceral leishmaniasis in east Africa.

Further to the excellent research coming out of KEMRI, the conference also highlighted special areas of public health interest through dedicated symposia focusing on road safety, neglected tropical diseases, bioethics, health systems and social sciences research, all addressing aspects of health and human/social development.

For the first time, a symposium on pharmaceutical and health products innovation, focusing solely on the business of the science addressed aspects of knowledge economy and industrialization.

DKDr. Solomon Mpoke, PhD, MBS,
Director, KEMRI

 

What's New

cocacola1








Dr. Nancy Quan, Global Vice President for Coco-Cola Research & Development (R&D) signs the Visitors Book when she visited KEMRI Headquarters on Tuesday, March 18th, 2014. Looking on are Dr. Elizabeth Bukusi, Deputy Director in charge of Research and Training and Dr. Charles Mwandawiro, Assistant Director in charge of Partnership & Collaborations.

More . . .

Coming Up

 

3rd KENYA INTERNATIONAL SCIENTIFIC LUNG HEALTH CONFERENCE

Read More . . .

 


 

CGHR ESACIPAC NTD CONFERENCE FLIER 2013 small

We have 88 guests online

Vision

"To be a leading centre of excellence in research for human health."

Mission

"To improve human health and quality of life through research, capacity building, innovation and service delivery."

Motto

"In Search of Better Health"
towards the realization of our Vision

Complaints

Do you have a complaint?
Click Here